Skip to main content
. 2023 Aug 16;15(8):2149. doi: 10.3390/pharmaceutics15082149

Figure 10.

Figure 10

Expression pattern of antifibrotic microRNAs and effect of Br-MSCs and/or their derived EXOs on their expression (AD). (A) Expression pattern of mir-29b, mir-181, and let-7b in Br-MSCs and their derived exosomes, (B) relative expression of renal mir-29b, (C) relative expression of renal mir-181, and (D) relative expression of renal Let-7b. Values are the means of (n) 6–8 rats per group ± S.E.M. *** p < 0.001, **** p < 0.0001.